UNSPSC 51273937: Epinephrine/lidocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN204. This VA Drug Class (CN204) classifies this compound as belonging to the group LOCAL ANESTHETICS, INJECTION.

UNSPSC 51273937 Epinephrine/lidocaine is a Commodity code that represents pharmaceutical products procured by state and local health agencies, counties, and cooperative purchasing alliances. The recent solicitations tagged to this code show state and local governments actually buying naloxone, generic multi-source pharmaceuticals, and over-the-counter products through both individual county procurement and multistate cooperative purchasing arrangements. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The work involves establishing supply contracts for pharmaceutical products with specified National Drug Codes, managing quarterly or ongoing deliveries, negotiating pricing structures with wholesalers, and ensuring compliance with FDA requirements, cGMP standards, and the Drug Supply Chain Security Act.

Recent activity spans Florida, Texas, and the upper Midwest. Representative solicitations include Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, awarded on a fixed-fee basis with a two-year initial term and one-year renewal option; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements; and MMCAP's S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multistate generic pharmaceutical and OTC product contracts with mandatory participation through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), requiring NDC-specific pricing, cGMP and DSCSA certification, and $2 million to $5 million in professional and commercial liability insurance, effective July 1, 2026.